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Multiple Sclerosis
Holly M. Hunt, BSN, RN
Otterbein University, Westerville, Ohio
Introduction
Multiple sclerosis (MS) is an
advanced pathophysiological
disease that is relevant to
advanced practice nursing. It is the
“most common immune-mediated
inflammatory demyelinating
disease of the central nervous
system” (Olek & Howard, 2019).
The exact cause of MS is still
unknown; however, it is
characterized by exacerbations of
neurological dysfunction due to
inflammatory demyelination
(Huang, Chen, & Zhang, 2017).
Consequently, the treatment of
MS requires a multi-disciplinary
approach, with nurses at the heart
of the team. Hence, an advanced
practice nurse will need to be able
to recognize the signs and
symptoms of MS for a proper
diagnosis and must be familiar
with the current trends in patient
management and treatments of
the disease. This help to support
and advocate for best available
intervention strategies acceptable
to the patient and relevant to
decrease chronic pathology.

Presentation of Case
A 69-year-old female diagnosed with MS 27 year ago. Symptoms began as
weakness in the left leg that would come and go. The weakness slowly spread to
the right side of the body. The patient went to the doctor when the right side
went completely weak. At the beginning of the disease process the patient was
not on any medications. When there was an exacerbation, the patient would be
off work for two or three weeks. Resting aided in recovery. No medications
were taken at this time.
The first MS drug tried was Betaseron, for approximately 10 years. During
this time there would be exacerbations approximately every two years. Rest and
IV steroids would aid in recovery.
The patient was taken off of Betaseron with a new neurologist due to the side
effect of depression, which the patient was experiencing. The medication
Copaxone was taken, but the results were not desired, so it was discontinued.
For several years the patient was not on any medication for MS. Two years ago,
Ocrevus was started. The patient is very pleased with the results. There are no
new lesions on the current MRI.
The main symptom the patient has is weakness in legs which has caused
progressive loss of function leading to using a progression from a cane, to a
walker, then to a wheelchair for mobility. Fatigue, incontinence, depression, and
feeling useless are other symptoms the patient reports.
Aggravating factors are heat, humidity, stress, and negative people. Relieving
factors are working on crafts, being outside when able, bible study, reading, and
watching tv. There is no family history of MS.

•

MS is the leading cause of
neurologic disability in
young to middle-aged
adults. This causes an
important socio-economic
impact (D’haeseleer, et al.,
2015) which nurses can
help address with proper
referral and treatment.
Due to the unpredictable
and highly variable course
MS takes it is important for
the multi-disciplinary team
to be well informed of the
pathophysiology of MS
(Feys et al., 2016).

The exact cause of MS is unknown. Many theories exist to answer this
question, several of which are listed below.
•
One widely accepted theory for the pathogenesis of MS is that it begins as
an inflammatory immune-medicated disorder (Olek & Mowry, 2019).
•
B cells through several mechanisms including the establishment of
ectopic lymphoid follicles within the CNS (Huang et al., 2017).
•
B cells are also thought to affect MS development by targeting
autoantigens (Arneth, 2019).
•
Cytokine and antibody production is another theory (Huang et al., 2017).
•
Tumor necrosis factor-alpha inhibitors could have a role in the cause of
MS (Olek & Mowry, 2019).
•
One theory suggests that the Epstein-Barr Virus (EBV) could cause MS.
The upregulation of antigen specific cytotoxic T cells stay in the body for
several years after the initial infection. Autoimmunity results when the
cytotoxic T cells target self-peptides in the CNS (Spagnuolo, Piavis, &
Williams, 2017).
•
While it is not understood what exact role heredity plays in developing
MS, there are some genes that lead to an increased risk. Specific genes
related to inflammation have been found with an increased risk of MS.
People who have dysregulation of T-cell differentiation have a higher
prevalence of MS (Spagnuolo et al., 2017).
•
Dendritic cells (DC) are part of the pathogenesis of MS. Different types
are found in white matter and cerebrospinal fluid of people who have MS
(Spagnuolo et al., 2017).

Implications for Nursing Care
The unknown exact cause of MS, the wide variety in symptoms, and the
unpredictability of the disease course has significant implications for the patient and
the nurse. Feys et al. (2016) suggests a multi-disciplinary approach to adequately
meet all of the patients complex and often changing needs. This team can include a
neurologist, nurse, primary care provider, other specialists, and professionals outside
of the health care sector (Feys et al., 2016).
Many new management options have been found in the past 20 years (D’haeseleer,
2015). Nurses need to keep up with changes in treatments to help educate patients
not only about current options, but side effects as well. The focus of the care needs to
be the improvement of quality of life and the patient’s ability to work (Kamm et al.,
2014). Suggestions for nurses can include linking the patient with accessibility
resources or occupational therapy. People who have MS noted the feeling of
invisibility (Žiaková, Čáp, Miertová, & Gurková, 2019). The nurse needs to keep this in
mind and address questions to the patient, not a care giver. The patient also might
have cognitive or speech delays and would need more time to answer questions. The
patients care giver is also affected, indirectly and must be considered by the nurse as
well (Feys et al., 2016).

Significance of Pathophysiology

Reason for
Study
•

Underlying Pathophysiology
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Signs & Symptoms
The signs and symptoms of MS vary depending on the affected part of
the Central Nervous System (CNS) (Arneth, 2019).
•
White matter plaque formation (Arneth, 2019)
•
Axonal injury (Arneth, 2019)
•
Demyelination (Arneth, 2019)
•
Sensory loss (Huang et al., 2017)
•
Visual disturbances (Huang et al., 2017)
•
Double vision (Huang et al., 2017)
•
Muscle weakness (Huang et al., 2017)
•
Ataxia (Huang et al., 2017)
•
Impaired balance (Huang et al., 2017)
•
Fatigue (Žiaková, Čáp, Miertová, & Gurková, 2019)
•
Exhaustion (Žiaková et al., 2019)
•
Bowel and bladder dysfunction (Arneth, 2019)
•
Depression (Kamm, Uitdehagg, & Polman, 2014)
•
Sleep disorders (Kamm, Uitdehagg, & Polman, 2014)
•
Spasticity (Kamm et al., 2014)
•
Tremor (Kamm et al., 2014)

In MS plaques form in the CNS and combined with inflammation,
demyelination, axonal injury and axonal loss are the defining processes of the
disease (Huang et al., 2017). The plaques are expressed in all of the forms of
MS. Over time the plaques disappear and return at different intervals (Huang
et, al. 2017). The location of the plaques dictates the symptoms expressed
and amount of disability the patient experiences.
The disease is progressive in nature and has different, defined types. A
person is first diagnosed when a sudden onset of a neurological symptom
compels a visit to the primary health care provider (Huang et al., 2017). The
relapsing remitting type of MS is exhibited by periods when the person is
symptomatic followed by times of no symptoms. Recovery from these
episodes can be complete or partial (Huang et al., 2017). This type of MS
often turns into a type of the disease called secondary progressive. This is
characterized by continuous irreversible neurological impairment between
relapses (Huang et al., 2017). In primary progressive MS the patient has a
gradually progressive course from the time of diagnosis (Huang et al. 2017).
There are no periods of remission. Progressive-relapsing MS is characterized
by a pattern of relapses while neurologic functions are worsening from the
onset of symptoms (Sevim, 2016).

Visual model of the different types of MS. Source:
http://commons.wikimedia.org/

Conclusions
Around the globe around 2.3 million people are diagnosed with MS (Arneth,
2019). The complex pathophysiology and insidious nature of the progression of the
disease makes care complicated. While all patients show destruction of the myelin
on the axons, symptoms vary widely depending on the location of the plaques. The
ability to interpret the exacerbation signs and symptoms of MS is an important
competency to possess. Nurses work as part of a multi- disciplinary team to
provide a wide range of treatment options. Excellent nursing care focuses on the
patient’s quality of life.
© iStock/noipornpan
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